Antitrombotisk behandling ved iskaemisk apopleksi og transitorisk cerebral iskaemi

Karsten Overgaard, Tina Svenstrup Poulsen, Steen E Husted

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

In acute ischemic stroke and transient ischemic attack (TIA), aspirin is recommended to all patients (except immediately following thrombolysis). Heparin and anticoagulant therapy using vitamin K antagonists should be avoided in the acute phase. Secondary preventive antithrombotic treatment includes anticoagulation in patients with cardioembolic stroke and antiplatelet agents aspirin possibly combined with dipyridamole or clopidogrel alone in patients with non-cardioembolic stroke. Other individual risks may modify this treatment regimen.
Udgivelsesdato: 2007-Oct-1
OriginalsprogDansk
TidsskriftUgeskrift for læger
Vol/bind169
Udgave nummer40
Sider (fra-til)3379-82
Antal sider3
ISSN0041-5782
StatusUdgivet - 1. okt. 2007

Citer dette

Overgaard, K., Poulsen, T. S., & Husted, S. E. (2007). Antitrombotisk behandling ved iskaemisk apopleksi og transitorisk cerebral iskaemi. Ugeskrift for læger, 169(40), 3379-82.
Overgaard, Karsten ; Poulsen, Tina Svenstrup ; Husted, Steen E. / Antitrombotisk behandling ved iskaemisk apopleksi og transitorisk cerebral iskaemi. I: Ugeskrift for læger. 2007 ; Bind 169, Nr. 40. s. 3379-82.
@article{e05eaef0e4a211deaefb000ea68e967b,
title = "Antitrombotisk behandling ved iskaemisk apopleksi og transitorisk cerebral iskaemi",
abstract = "In acute ischemic stroke and transient ischemic attack (TIA), aspirin is recommended to all patients (except immediately following thrombolysis). Heparin and anticoagulant therapy using vitamin K antagonists should be avoided in the acute phase. Secondary preventive antithrombotic treatment includes anticoagulation in patients with cardioembolic stroke and antiplatelet agents aspirin possibly combined with dipyridamole or clopidogrel alone in patients with non-cardioembolic stroke. Other individual risks may modify this treatment regimen. Udgivelsesdato: 2007-Oct-1",
keywords = "Aspirin, Brain Ischemia, Dipyridamole, Drug Therapy, Combination, Fibrinolytic Agents, Humans, Ischemic Attack, Transient, Platelet Aggregation Inhibitors, Recurrence, Stroke, Thromboembolism, Ticlopidine",
author = "Karsten Overgaard and Poulsen, {Tina Svenstrup} and Husted, {Steen E}",
year = "2007",
month = "10",
day = "1",
language = "Dansk",
volume = "169",
pages = "3379--82",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "40",

}

Overgaard, K, Poulsen, TS & Husted, SE 2007, 'Antitrombotisk behandling ved iskaemisk apopleksi og transitorisk cerebral iskaemi', Ugeskrift for læger, bind 169, nr. 40, s. 3379-82.

Antitrombotisk behandling ved iskaemisk apopleksi og transitorisk cerebral iskaemi. / Overgaard, Karsten; Poulsen, Tina Svenstrup; Husted, Steen E.

I: Ugeskrift for læger, Bind 169, Nr. 40, 01.10.2007, s. 3379-82.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Antitrombotisk behandling ved iskaemisk apopleksi og transitorisk cerebral iskaemi

AU - Overgaard, Karsten

AU - Poulsen, Tina Svenstrup

AU - Husted, Steen E

PY - 2007/10/1

Y1 - 2007/10/1

N2 - In acute ischemic stroke and transient ischemic attack (TIA), aspirin is recommended to all patients (except immediately following thrombolysis). Heparin and anticoagulant therapy using vitamin K antagonists should be avoided in the acute phase. Secondary preventive antithrombotic treatment includes anticoagulation in patients with cardioembolic stroke and antiplatelet agents aspirin possibly combined with dipyridamole or clopidogrel alone in patients with non-cardioembolic stroke. Other individual risks may modify this treatment regimen. Udgivelsesdato: 2007-Oct-1

AB - In acute ischemic stroke and transient ischemic attack (TIA), aspirin is recommended to all patients (except immediately following thrombolysis). Heparin and anticoagulant therapy using vitamin K antagonists should be avoided in the acute phase. Secondary preventive antithrombotic treatment includes anticoagulation in patients with cardioembolic stroke and antiplatelet agents aspirin possibly combined with dipyridamole or clopidogrel alone in patients with non-cardioembolic stroke. Other individual risks may modify this treatment regimen. Udgivelsesdato: 2007-Oct-1

KW - Aspirin

KW - Brain Ischemia

KW - Dipyridamole

KW - Drug Therapy, Combination

KW - Fibrinolytic Agents

KW - Humans

KW - Ischemic Attack, Transient

KW - Platelet Aggregation Inhibitors

KW - Recurrence

KW - Stroke

KW - Thromboembolism

KW - Ticlopidine

M3 - Tidsskriftartikel

VL - 169

SP - 3379

EP - 3382

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 40

ER -